BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/15/2017 6:16:31 AM | Browse: 1287 | Download: 2494
 |
Received |
|
2016-12-15 15:19 |
|
Peer-Review Started |
|
2016-12-17 20:12 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2017-01-04 20:19 |
|
Revised |
|
2017-01-27 01:13 |
|
Publication Fee Transferred |
|
2017-04-14 13:34 |
|
Second Decision by Editor |
|
2017-03-09 13:25 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2017-03-15 12:14 |
|
Articles in Press |
|
2017-03-15 12:14 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-04-25 18:26 |
|
Publish the Manuscript Online |
|
2017-05-15 06:16 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Thiopurine use associated with reduced B and natural killer cells in inflammatory bowel disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
James D Lord and Donna M Shows |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Virginia Mason Medical Center, Digestive Disease Institute Research Grant Award |
0506812-2011 |
|
| Corresponding Author |
James D Lord, MD, PhD, Research Assistant Member, Translational Research Program, Benaroya Research Institute, 1201 Ninth Avenue, Seattle, WA 98101, United States. jlord@benaroyaresearch.org |
| Key Words |
Thiopurine; Azathioprine; Mercaptopurine; Lymphocyte; Natural killer cell; Transitional B cell; Inflammatory bowel disease |
| Core Tip |
Thiopurine medications have been used to treat inflammatory bowel disease (IBD) for almost half a century. However, the effect of thiopurines on the human immune system in vitro remains unclear. The enclosed manuscript performed a thorough flow cytometric analysis of peripheral blood specimens from IBD patients with or without thiopurine therapy and found significant differences in B and NK cell populations associated with therapy. These suggest that thiopurines function to suppress inflammation in IBD not by causing T cell apoptosis, as had been suggested by in vitro data, but rather by depleting other lymphocytes. |
| Publish Date |
2017-05-15 06:16 |
| Citation |
Lord JD, Shows DM. Thiopurine use associated with reduced b and natural killer cells in inflammatory bowel disease. World J Gastroenterol 2017; 23(18): 3240-3251 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i18/3240.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i18.3240 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
